Literature DB >> 18047431

Treatment of micropapillary carcinoma of the thyroid: where do we draw the line?

I Ross McDougall1, Carlos A Camargo.   

Abstract

Two patients with papillary thyroid cancer were seen in consultation after they had been treated in other medical centers. Their cancers measured 1 and 1.2 mm, respectively. Both patients were treated by two thyroid operations and (131)I ablation. We believe that, apart from lobectomy, these therapies were not justified. We draw attention to this to provide a topic for debate and to attempt to prevent this happening to other patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18047431     DOI: 10.1089/thy.2007.0203

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Total versus hemithyroidectomy for microscopic papillary thyroid cancer.

Authors:  M Gershinsky; O Barnett-Griness; N Stein; D Hirsch; G Tzvetov; O Bardicef; J Pauker; S Grozinsky-Glasberg; S Ish-Shalom; I Slutski; I Shimon; C Benbassat
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

2.  Using foci number to predict central lymph node metastases of papillary thyroid microcarcinomas with multifocality.

Authors:  Yawen Guo; Zeming Liu; Pan Yu; Chunping Liu; Jie Ming; Ning Zhang; Maimaiti Yusufu; Chen Chen; Tao Huang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Thyroid lobectomy in patients with differentiated thyroid cancer: an analysis of the clinical outcomes in a nationwide multicenter study.

Authors:  Juan J Díez; Victoria Alcázar; Pedro Iglesias; Ana Romero-Lluch; Julia Sastre; Begoña Pérez Corral; Carles Zafón; Juan Carlos Galofré; María José Pamplona
Journal:  Gland Surg       Date:  2021-02

4.  Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?

Authors:  Carmelo Nucera; Alfredo Pontecorvi
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-27       Impact factor: 5.555

5.  Adjuvant Radioactive iodine 131 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience [corrected].

Authors:  Khalid Hussain Al-Qahtani; Mushabbab Al Asiri; Mutahir A Tunio; Naji J Aljohani; Yasser Bayoumi; Hanadi Fatani; Abdulrehman AlHadab
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-12-01

6.  Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience.

Authors:  Pierre Heudel; Fadi El Karak; Nabil Ismaili; Jean-Pierre Droz; Aude Flechon
Journal:  BMC Urol       Date:  2009-06-17       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.